This story idea came from audience members, like you, who got in touch with us. Send us all of your questions about COVID-19. We are listening: ask@cbc.ca.
Now that Health Canada has approved Pfizer’s COVID-19 therapeutic Paxlovid for use in people 18 and older, CBC News has been receiving questions about how it works and what its limitations are.
For starters, it’s an oral antiviral treatment. In other words, pills that help you fight off the symptoms of COVID-19.
But here’s a closer look at the ins and outs of the treatment.
How does it work?
Paxlovid consists of two antiviral drugs packaged together:
